Lv1
40 积分 2024-11-01 加入
Optimizing bridging radiotherapy prior to CAR-T cell therapy: An evidence-based approach
6天前
已关闭
Implications of High Tumor Burden on Chimeric Antigen Receptor T-Cell Immunotherapy
8天前
已完结
Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion
9天前
已完结
From R-CHOP to revolution: How CAR T-Cells, ADCs, and bispecific antibodies are transforming DLBCL treatment
10天前
已完结
Optimizing bridging radiotherapy prior to CAR-T cell therapy: An evidence-based approach
15天前
已关闭
Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial
22天前
已完结
Outcomes of allogeneic or autologous stem cell transplantation followed by maintenance chemotherapy in adult patient with B‐ALL in CR1 with no detectable minimal residual disease
28天前
已完结
Allogeneic hematopoietic stem cell transplantation following T-cell-directed immunotherapy failure in B-cell lymphoma: a real-world case series and systematic literature review
1个月前
已完结
Periplogenin inhibits pyroptosis of fibroblastic synoviocytes in rheumatoid arthritis through the NLRP3/Caspase-1/GSDMD signaling pathway
1个月前
已完结
Who Is Eligible for CAR T-Cell Therapy? Expert Perspectives on Overcoming Referral Barriers
1个月前
已完结
皖公网安备34019202002308
